Core Viewpoint - The company ST Lingnan announced a partial repayment plan for its remaining convertible bonds, indicating ongoing financial challenges and potential risks related to litigation and debt repayment [1] Group 1: Bond Repayment - The company will partially repay 3,790,367 remaining "Lingnan Convertible Bonds" by February 10, 2026, with 20.0433 million yuan allocated for the third phase of repayment [1] - Funds will be distributed on February 10, following the application for cancellation of the remaining bonds on February 6 [1] Group 2: Legal and Financial Risks - As of February 4, the company and its subsidiaries have faced new litigation and arbitration with a total amount involved of approximately 142.9109 million yuan, which represents 13.42% of the latest audited net assets attributable to the parent company [1] - The company is at risk of failing to repay bonds on time, facing ongoing operational challenges, and potential stock delisting due to these financial issues [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、退市警报拉响 2026年1月31日，ST岭南（维权）发布《2025年年度业绩预告》，ST岭南的财务指标同时触及了《深圳 证券交易所股票上市规则》第9.3.1条中的两项退市红线：最近一个会计年度的利润总额、净利润和扣非 净利润三者孰低为负值，且扣除后的营业收入低于3亿元；同时，期末净资产也为负值。 根据《深圳证券交易所股票上市规则》相关规定，公司股票交易可能在披露《2025年年度报告》后被实 施退市风险警示，股票简称前将冠以"*ST"字样。 ST岭南的情况尤为复杂。该公司此前已连续三年亏损，累计亏损超过36亿元。2024年，其内部控制审 计报告被年审会计师事务所出具了否定意见。 随后在2025年9月，公司及原控股股东收到中国证券监督管理委员会出具的《立案告知书》，因涉嫌信 息披露违法违规，中国证监会已正式决定对公司及原控股股东立案。 二、立案或早有端 ...

Core Viewpoint - ST Lingnan announced that "Lingnan Convertible Bonds" cannot be redeemed on time, and its credit rating has been downgraded to C [1] Financial Performance - The company's revenue has been continuously declining, with projected revenue for 2024 at 862 million, a year-on-year decrease of 59.55%, and a net loss of 984 million, with losses narrowing by 9.86% [1] - For the first nine months of 2025, the revenue is expected to be 253 million, a year-on-year decrease of 68.75%, with a net loss of 206 million, and losses narrowing by 23.34% [1] Risks and Challenges - The company faces ongoing operational challenges, risks related to the realization of pledged assets in the credit enhancement plan, potential stock delisting, and litigation issues [1] - Recently, due to a financial loan contract dispute, the company and its subsidiaries have been named as third parties in a lawsuit, with the impact of the case currently unknown [1]

Core Viewpoint - ST Lingnan announced that "Lingnan Convertible Bonds" cannot be redeemed on time for principal and interest, leading to a downgrade of the company's and the bond's credit rating to C by United Ratings [1] Financial Performance - The company's revenue for 2024 is projected to be 862 million, a year-on-year decline of 59.55%, with a net loss of 984 million, which is a reduction in loss scale by 9.86% compared to the previous year [1] - For the first nine months of 2025, the revenue is expected to be 253 million, reflecting a year-on-year decrease of 68.75%, with a net loss of 206 million, which is a reduction in loss by 23.34% compared to the same period last year [1] Risks and Challenges - There are ongoing risks related to the monetization of pledged assets under the credit enhancement plan, potential delisting of the company's stock, and litigation issues [1] - The company will hold the second bondholders' meeting for "Lingnan Convertible Bonds" on December 29 [1]

Group 1 - The People's Bank of China will conduct a 700 billion yuan reverse repurchase operation today, with a term of 3 months (91 days) [3] - The China Securities Regulatory Commission emphasizes risk prevention, strong regulation, and promoting high-quality development in the capital market, with plans for more open measures [4] - The National Healthcare Security Administration announced that the negotiation for the 2025 National Basic Medical Insurance Drug List has concluded, with a new list to be published in December and implemented from January 1, 2026 [4] Group 2 - True Love Home announced a potential change in control, leading to a suspension of trading from November 5, with the suspension expected to last no more than two trading days [8] - Shida Group plans to acquire 95% of Fujian Shuchan Ming Shang Technology Co., with an estimated transaction price of 185 million yuan, aimed at enhancing its main business revenue and market competitiveness [8] - Fuyao Glass has completed the registration of a change in its legal representative, with no other changes to its business license [10]

Market Overview - The U.S. stock market experienced significant declines, with the S&P 500 and Nasdaq recording their largest single-day drops since October 10. The Dow Jones fell by 0.53%, the S&P 500 dropped by 1.17%, and the Nasdaq decreased by 2.04% [4] - Major technology stocks mostly declined, with notable drops including Nvidia down 3.96% and Tesla down 5.15%. Only Apple saw a slight increase of 0.37% [4] - Cryptocurrency assets faced pressure, with Ethereum falling below $3100, a drop of 14%, and Bitcoin decreasing over 7%, nearing the $99,000 mark [4] Commodity Market - International oil prices fell, with WTI crude oil futures down by $0.49 to $60.56 per barrel, a decrease of 0.80%. Brent crude oil also fell by $0.45 to $64.44 per barrel, down 0.69% [5] - COMEX gold futures dropped by $53.50, settling at $3960.5 per ounce, reflecting a decline of 1.33% [5] Company News - Xpeng Motors held a technology day event, showcasing advancements and future plans [2] - Meituan has repurchased A-shares totaling 9.575 billion yuan [7] - Standard Shares indicated that its stock price may be subject to market sentiment risks [7] - ST Lingnan is facing legal issues related to collusion in bidding [7] Policy and Economic Outlook - Huachuang Securities predicts a policy vacuum in the next 1-2 months, suggesting potential market fluctuations [8] - Dongwu Securities remains optimistic about the market's ability to challenge the 4000-point mark, while cautioning about individual stock movements [8] - Huashang Securities maintains a steady outlook despite short-term market fluctuations, citing improvements in the fundamental market conditions and policy support for long-term capital inflows [8]

Group 1 - The People's Bank of China will conduct a 700 billion yuan reverse repurchase operation with a term of 3 months (91 days) [1] - The China Securities Regulatory Commission emphasizes risk prevention, strong regulation, and promoting high-quality development in the capital market [1] - The new version of the basic medical insurance drug catalog and the first version of the commercial insurance innovative drug catalog are expected to be released in December and implemented from January 1, 2026 [2][3] Group 2 - True Love Home announced a potential change in control, leading to a suspension of trading from November 5, with an expected duration of no more than 2 trading days [5] - Shida Group plans to acquire 95% of Fujian Shuchan Ming Shang Technology Co., Ltd. for 185 million yuan, which is expected to enhance its main business revenue and profit scale [5] - Fuyao Glass has completed the registration of a change in its legal representative, with no other changes to its business license [7] Group 3 - The implementation of artificial intelligence in healthcare is set to enhance the quality of health services, with a goal to establish high-quality data sets and intelligent applications by 2027 [4] - The China Securities Regulatory Commission aims to improve the efficiency of overseas listing filings and expand the scope of stock trading through the Shanghai-Hong Kong Stock Connect [2]

Core Viewpoint - ST Lingnan has been indicted for collusion in bidding, which may impact its operations and financials pending court judgment [2][3] Legal Issues - The company received a summons from the People's Court of Tangyin County, Henan Province, with a court date set for October 31, 2025 [3] - The company reported a total of approximately 131 million yuan in litigation and arbitration cases over the past twelve months, representing 12.28% of its latest audited net assets [3] Financial Performance - For the first three quarters of 2025, the company reported revenues of approximately 253 million yuan, a year-on-year decline of 68.75% [4] - The net profit attributable to shareholders was approximately -206 million yuan, indicating a reduction in losses compared to the previous year [4] Shareholder Actions - Shareholder Yin Hongwei's 20 million shares (1.10% of total shares) were sold at auction for approximately 36.29 million yuan on November 2 [5] - As of November 3, Yin Hongwei had approximately 208 million shares frozen and 1.294 billion shares under pending judicial actions, indicating potential future disposals [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 股价跌破2元！这家公司，涉嫌串通投标罪，被起诉 11月4日晚，ST岭南（维权）公告称，公司涉嫌串通投标罪被起诉。 同日，公司还发布了另一则公告，股东尹洪卫所持的2000万股股份（占公司总股本的1.10%）于11月2 日被广东省东莞市中级人民法院在京东网络司法拍卖平台上进行司法变卖。 Wind数据显示，截至11月4日收盘，公司股价报1.93元/股，收跌3.02%，总市值约为35亿元。 涉嫌串通投标罪 公告显示，ST岭南近日收到河南省汤阴县人民法院送达的传票，开庭日期为2025年10月31日上午8时30 分。公司涉嫌串通投标罪被起诉，公司将积极配合公安机关、法院做好相关工作，依法采取有效措施。 图片来源：同花顺 截至目前，上述事件暂未对公司的生产经营产生重大影响。此次事件是否对公司经营、财务方面产生影 响有待法院进一步判决。公司将持续关注上述事件的进展情况并及时履行信息披露义务。 10月30日晚，ST岭南披露关于累计诉讼、仲裁情况的公告。公告显示，截至2025年10月28日，公司及 控股子公 ...

ST岭南公告称，持股5%以上股东尹洪卫所持2000万股（占总股本1.10%）被司法变卖，竞买人卢闯以 3628.8万元竞得，最终成交以法院裁定为准。截至公告披露日，尹洪卫累计被拍卖股份1.66亿股，占其 所持股份的79.77%，占公司总股本的9.11%。若本次及此前被拍卖的股份完成过户，尹洪卫持股将降至 1.01亿股，占比降至5.56%；控股股东及其一致行动人表决权股份降至2.04亿股，占比降至11.18%，均 触及权益变动。 ...